Microcarrier patent to be auctioned

Sedum Laboratories, Inc., formerly of Mansfield, Mass., is auctioning its U.S. Patent #6,645,525 titled "Ionically Formulated Biomolecule Microcarriers."

The untimely death of its founder and driving force of its principal technology, James Woiszwillo, has lead to the dissolution of the research and development company. Several major pharmaceutical companies were in various stages of evaluation.

According to Joseph Popolo, CEO of IpAuctions, Inc., “Woiszwillo, as Chief Scientific Officer, had over 30 years experience in product development, and holds 13 patents, including five in the field of drug development.” He was also the founder of Epic Therapeutics, a drug delivery company that was purchased by Baxter Healthcare.

The patent has been reported in numerous pharmaceutical journals, all of which are available online. Sedum Labs’ Business and Strategic Plans are accessible at www.IpAuctions.com.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New biomarkers offer hope for early detection and prevention of Alzheimer's